Nov 13 (Reuters) - Prometic Life Sciences Inc
* Prometic reports 2017 third quarter highlights and financial results
* Q3 revenue C$24 million versus C$3.7 million
* Q3 revenue view c$6.9 million -- Thomson Reuters I/B/E/S
* Prometic Life Sciences - incurred a net loss of $17.8 million for quarter ended sept 30, compared to net loss of $28.0 million for quarter ended Sept 30, 2016 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.